A-Kinase Anchoring Protein Dysregulation during Alcohol-Associated Liver Disease
酒精相关性肝病期间 A 激酶锚定蛋白失调
基本信息
- 批准号:10705602
- 负责人:
- 金额:$ 33.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:A kinase anchoring proteinAdipose tissueAdrenergic ReceptorAffectAlcoholic Liver DiseasesAlcoholsBindingCell membraneCyclic AMPCyclic AMP-Dependent Protein KinasesCyclin D1DataDevelopmentDisease ProgressionEnzymesEventExhibitsFatty LiverFatty acid glycerol estersFunctional disorderGravinHepatic Stellate CellHepatocyteHomeostasisHsp47 proteinHumanImpairmentLipaseLipidsLipolysisLiteratureLiverLiver diseasesLocationMapsMediatingMicroRNAsMusMutateMutationNatureOutcomePathway interactionsPatternPhosphopeptidesPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesProcessProtein KinaseProteinsProteomicsPublishingRationalizationRecyclingRegulationRoleScaffolding ProteinSignal TransductionSiteTestingTherapeuticTriglyceridesWorkalcohol effectalcohol exposurecomparison controlcrosslinkdesensitizationfatty acid oxidationlipid biosynthesisliver injurymRNA ExpressionmRNA Stabilitymouse modelnovelpreservationpreventprotein expressionrab GTP-Binding Proteinsrecruitscaffoldspatiotemporaltrafficking
项目摘要
PROJECT SUMMARY
Fatty liver potentiates alcohol-associated liver disease (ALD) development. AKAP12 (A-kinase anchoring protein
12) is a scaffolding protein in signal transduction by anchoring protein kinases (PKA, PKC), cyclin-D1 and heat
shock protein 47. Our recent proteomics studies showed that AKAP12 exhibited decreased interaction with
kinases and increased interaction with phosphatases by alcohol in mouse models and human ALD. This led us
to examine whether alcohol regulated AKAP12 phosphorylation. By phospho-peptide mapping we determined
that alcohol strongly inhibited AKAP12 phosphorylation in mouse liver. AKAP12’s alcohol-sensitive phospho-
sites were mainly PKA-predicted substrates. Mutating these phospho-sites reduced the stability of AKAP12
protein, suggesting that phosphorylation stabilized AKAP12. The AKAP12 interactome revealed its interactions
with proteins known to regulate lipid homeostasis such as PKA, 2-adrenergic receptor (2-AR) and lipolytic
enzymes, adipose-triglyceride lipase (ATGL). We therefore assessed the functional role of this AKAP12
interactome in hepatocytes. It was shown previously that AKAP12-mediated PKA scaffolding recruits it to 2-
AR. The signalosome of AKAP12, PKA and 2-AR regulates cAMP levels through the process of 2-AR de-
sensitization/re-sensitization and may involve AKAP12 phosphorylation. 2-AR/PKA/cAMP signaling limits lipid
accumulation and enhances lipolysis. Our novel preliminary data indicates that alcohol exposure dysregulates
several components of the AKAP12/PKA/2-AR signalosome. Alcohol inhibited the interaction between PKA and
2-AR. AKAP12 was highly phosphorylated at a S696-S698 PKA-phospho-site that was previously published to
facilitate AKAP12-2-AR binding. This site exhibited decreased phosphorylation upon alcohol exposure and
mutating this AKAP12 site reduced its scaffolding towards both PKA and 2-AR. This AKAP12 mutation also
reduced 2-AR protein stability. Alcohol interfered with AKAP12-2-AR interaction and facilitated AKAP12 and
2-AR lysosomal degradation. Based on these data, we hypothesize that decreased AKAP12 phosphorylation
following alcohol exposure might interfere with AKAP12/PKA/2-AR signalosome, causing alterations in cAMP
signaling, which in turn could dysregulate lipid homeostasis. Preliminary data that support this hypothesis are:
1) Enhancing endogenous AKAP12 levels reverses the inhibitory effect of alcohol on PKA-2-AR interaction; 2)
AKAP12 induction inhibits alcohol-mediated increase of triglyceride levels; 3) AKAP12 induction reverses
alcohol’s suppressive effect on fatty acid oxidation. Induction of AKAP12 also reverses alcohol’s suppressive
effect on the activity of lipolytic enzyme, ATGL. Whether the AKAP12/PKA/2-AR scaffold controls lipid
homeostasis is unknown. We hypothesize that dysregulation of the AKAP12 signalosome favors lipid
accumulation. This proposal will evaluate how alcohol-sensitive AKAP12 phosphorylation destabilizes AKAP12,
impairs its scaffolding activities and contributes to dysregulation of lipid homeostasis. The therapeutic benefit of
AKAP12 phospho-stabilization in ameliorating lipid dysfunction will be tested in mouse models of ALD.
项目总结
脂肪肝加剧了酒精相关性肝病(ALD)的发展。AKAP12(A-激酶锚定蛋白
12)是一种通过锚定蛋白激酶(PKA、PKC)、细胞周期蛋白-D1和热进行信号转导的脚手架蛋白
休克蛋白47。我们最近的蛋白质组学研究表明,AKAP12与
在小鼠模型和人类ALD模型中,乙醇与磷酸酶的相互作用增加。这让我们
检测酒精是否调节AKAP12的磷酸化。通过磷酸肽图确定了
酒精对小鼠肝脏AKAP12的磷酸化有强烈的抑制作用。AKAP12‘S酒精敏感磷酸盐
位点主要是PKA预测的底物。突变这些磷酸基降低了AKAP12的稳定性
蛋白质,这表明磷酸化稳定了AKAP12。AKAP12相互作用组揭示了其相互作用
具有调节脂质稳态的已知蛋白质,如PKA、2-肾上腺素能受体(2-AR)和脂解
酶,脂肪甘油三酯脂肪酶(ATGL)。因此,我们评估了该AKAP12的功能作用
肝细胞中的相互作用体。以往的研究表明,AKAP12介导的PKA支架将其招募到2-
阿。AKAP12、PKA和2-AR信号小体通过2-AR去激活调节cAMP水平。
敏化/再敏化,可能涉及AKAP12的磷酸化。2-AR/PKA/cAMP信号通路限制血脂
积聚并增强脂肪分解作用。我们新的初步数据表明,酒精暴露会导致
AKAP12/PKA/2-AR信号体的几个组分。酒精可抑制PKA和PKA之间的相互作用
2-AR。AKAP12在S696-S698的PKA磷酸化位点高度磷酸化,该位点之前发表于
促进AKAP12-2-AR结合。在酒精暴露下,这个部位的磷酸化水平降低,
突变这个AKAP12位点减少了它对PKA和2-AR的支架作用。这个AKAP12突变也
降低2-AR蛋白的稳定性。酒精干扰AKAP12-2-AR相互作用促进AKAP12和
2-AR溶酶体降解。基于这些数据,我们假设AKAP12的磷酸化水平降低
酒精暴露可能干扰AKAP12/PKA/2-AR信号体,导致cAMP改变
信号,这反过来可能会扰乱脂类平衡。支持这一假设的初步数据是:
1)提高内源性AKAP12水平可逆转酒精对PKA--2-AR相互作用的抑制作用;
AKAP12诱导抑制酒精诱导的甘油三酯水平升高;3)AKAP12诱导逆转
酒精对脂肪酸氧化的抑制作用。AKAP12的诱导也可逆转酒精的抑制作用
对脂解酶ATGL活性的影响。AKAP12/PKA/2-AR支架是否控制血脂
动态平衡是未知的。我们假设AKAP12信号体的失调有利于脂质
积累。这项提案将评估酒精敏感的AKAP12磷酸化如何破坏AKAP12的稳定,
损害其支架活性,并导致脂质平衡失调。治疗方面的好处
AKAP12在改善脂质紊乱方面的磷酸化稳定性将在ALD的小鼠模型中进行测试。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models.
- DOI:10.7554/elife.78430
- 发表时间:2022-10-04
- 期刊:
- 影响因子:7.7
- 作者:Ramani K;Mavila N;Abeynayake A;Tomasi ML;Wang J;Matsuda M;Seki E
- 通讯作者:Seki E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Komal Ramani其他文献
Komal Ramani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Komal Ramani', 18)}}的其他基金
A-Kinase Anchoring Protein Dysregulation during Alcohol-Associated Liver Disease
酒精相关性肝病期间 A 激酶锚定蛋白失调
- 批准号:
10416315 - 财政年份:2022
- 资助金额:
$ 33.4万 - 项目类别:
Role of A-Kinase Anchoring Proteins in Hepatotoxin- Induced Liver Fibrosis
A-激酶锚定蛋白在肝毒素诱导的肝纤维化中的作用
- 批准号:
9893423 - 财政年份:2019
- 资助金额:
$ 33.4万 - 项目类别:
Role of A-Kinase Anchoring Proteins in Hepatotoxin- Induced Liver Fibrosis
A-激酶锚定蛋白在肝毒素诱导的肝纤维化中的作用
- 批准号:
10022305 - 财政年份:2019
- 资助金额:
$ 33.4万 - 项目类别:
Methionine Adenosyltransferase as a Therapeutic Target for Liver Fibrosis
蛋氨酸腺苷转移酶作为肝纤维化的治疗靶点
- 批准号:
8475416 - 财政年份:2011
- 资助金额:
$ 33.4万 - 项目类别:
Methionine Adenosyltransferase as a Therapeutic Target for Liver Fibrosis
蛋氨酸腺苷转移酶作为肝纤维化的治疗靶点
- 批准号:
8318437 - 财政年份:2011
- 资助金额:
$ 33.4万 - 项目类别:
Methionine Adenosyltransferase as a Therapeutic Target for Liver Fibrosis
蛋氨酸腺苷转移酶作为肝纤维化的治疗靶点
- 批准号:
8322835 - 财政年份:2011
- 资助金额:
$ 33.4万 - 项目类别:
Methionine Adenosyltransferase as a Therapeutic Target for Liver Fibrosis
蛋氨酸腺苷转移酶作为肝纤维化的治疗靶点
- 批准号:
7660580 - 财政年份:2009
- 资助金额:
$ 33.4万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 33.4万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 33.4万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 33.4万 - 项目类别:














{{item.name}}会员




